Business Context and Reporting Period
This Form 8-K was filed by Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) on August 2, 2018. The report covers the fiscal quarter ended June 30, 2018, and details a corporate name change effective August 17, 2018.
Financial Metrics
The filing references the announcement of financial results for the quarter ended June 30, 2018, in Item 2.02 and Item 7.01. However, the specific text of this Form 8-K does not provide numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are incorporated by reference but not included in the source text provided.
Material Changes
- Corporate Name Change: The Board of Directors amended the Certificate of Incorporation and Bylaws to change the company name from "Prestige Brands Holdings, Inc." to "Prestige Consumer Healthcare Inc." effective August 17, 2018.
- Bylaw Amendments: Significant updates were made to the Bylaws, including the elimination of the right for stockholders to act by written consent and enhanced advance notice requirements for director nominations and business proposals.
Guidance, Outlook, and Risks
Management began investor presentations on August 2, 2018, utilizing an Investor Presentation (Exhibit 99.2) intended for use throughout the fiscal year ended March 31, 2019. The filing includes standard disclaimers that the information in the presentation is summary in nature and that the company undertakes no obligation to update or revise the information publicly.
Key Facts for Investor Verification
- Verify the specific Q2 2018 financial results (revenue, EPS, cash flow) in the attached Press Release (Exhibit 99.1) as they are not listed in the main body of this filing.
- Confirm the effective date of the name change to "Prestige Consumer Healthcare Inc." is August 17, 2018.
- Review the new Bylaws (Exhibit 3.2) regarding the removal of stockholder written consent rights and stricter nomination deadlines.
- Check the Investor Presentation (Exhibit 99.2) for management's outlook for the fiscal year ending March 31, 2019.